GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,640.00
Bid: 1,637.50
Ask: 1,638.00
Change: -10.50 (-0.64%)
Spread: 0.50 (0.031%)
Open: 1,650.50
High: 1,658.50
Low: 1,627.50
Prev. Close: 1,650.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-U.S. tax hike less likely: a boon for Europe Inc too

Thu, 05th Nov 2020 10:08

* European shares open higher led by tech

* Strong Q3 earnings reports also help

* Bank of England ramps up stimulus

* Wall Street futures point to more gains
Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You
can share your thoughts with us at markets.research@thomsonreuters.com

U.S. TAX HIKE LESS LIKELY: A BOON FOR EUROPE INC TOO (0957 GMT)

A gridlock in Washington with Biden president and Republicans retaining the Senate is a
scenario that's becoming more likely and equity investors are starting to appreciate the lower
likelihood of business unfriendly policy.

And the possible benefits for corporates, especially on the tax front, are going to be felt
on both sides of the pond.

"President Trump cut the U.S. corporation tax rate from 35% to 21%. The Democrats were
intending to raise it back to 28%. That prospect now seems less likely, which should help U.S.
equities," say Citi strategists.

"It should also boost non-US companies with significant US businesses. Their relative
performance has flat-lined recently," they added.

Several shares in European companies with big presence in the U.S. are doing relatively well
since it emerged that Trump was doing better than expected by the polls.

In the snapshot you can see today's price moves of a basket of European stocks with high
revenue exposure to North America. The basket, which includes names such as Deutsche Telekom
, UBS, Roche and National Grid, is courtesy of Citi.

(Danilo Masoni)

*****

OPENING SNAPSHOT: STRONG Q3, TECH RALLY AND MORE UK STIMULUS (0854 GMT)

European bourses are well in positive territory supported by a batch of positive Q3 results
and more stimulus in the UK as the country starts a second national lockdown.

The pan-European STOXX 600 index is up 0.8% to its highest level since Oct. 20,
with the tech sector leading the gains, up 2.5%.

Britain's blue chips are up 0.3% after the Bank of England increased its already
huge bond-buying stimulus by a bigger-than-expected 150 billion pounds to 895 billion pounds.
The BoE kept the bank rate at 0.1%.

In terms of single companies, Milan-listed Tenaris is set for its best day in 9
years after reporting strong Q3 results, it was last up more than 11%.

(Joice Alves)

*****

ON THE RADAR: BANKS Q3, ARCELORMITTAL, SAINSBURY (0746 GMT)

Looking at futures, it seems like it is going to be a start of the day in the black for
European bourses in a data heavy morning, which also sees investors having to digest a slew of
earnings results.

There is a mixed batch of banking Q3 results with France's third-biggest listed bank Societe
Generale swinging back to profit, as its equity trading business continued to recover
from a weak start to the year; and Italy's second-biggest bank UniCredit posted much
higher than expected net profit as Europe emerged from lockdowns.

In the meantime, Germany's Commerzbank swung to a Q3 loss, as the lender undergoes
a restructuring.

ING Groep, the largest Dutch bank, reported lower than expected pre-tax profit of
1.20 billion euros on declining interest income amid the coronavirus pandemic and said it
intends to cut 1,000 jobs.

British supermarket group Sainsbury also said it could cut 3,500 jobs in a
restructuring.

On a brighter note, ArcelorMittal, the world's largest steelmaker, reported Q3 core
profit above expectations as the easing of lockdowns led to improved demand.
German broadcaster ProSiebenSat.1 Media returned to profit, and reinstated its FY
guidance. Its shares rose 5.7% in premarket trade.

HeidelbergCement, the world's No.2 cement maker, posted a 13% increase in Q3 core
profit, as cost cuts helped it to shrug off the impact of the pandemic and forecast higher
earnings for 2020.

Siemens Gamesa keeps profit target as Q4 uptick fails to stave off loss.

British insurer RSA's underwriting profit rose strongly in the first nine months of
2020 due to improvements the company made to its underwriting strategy.

German reinsurance group Munich Re's net profit declined 77% to 199 million euros
in Q3.

Staying in Germany, specialty chemicals maker Lanxess narrowed its 2020 core
profit outlook range after the coronavirus pandemic, saying it was seeing a pick up in the auto
industry, with China and the U.S. also providing positive stimuli.

While Lufthansa said it booked a net loss of 2 billion euros in Q3.

Sunrise Communications announced plans to boost its 2020 dividend to 4.55 and 4.65
Swiss francs per share, from 4.4 francs, ahead of the Swiss telecommunications firm's takeover
by Liberty Global that will lead to its delisting.

(Joice Alves)

*****

MORNING CALL: STILL NO U.S. PRESIDENT (0638 GMT)

Futures are pointing to gains for European bourses this morning mirroring Asian shares,
which climbed on the prospect that a gridlock in the U.S. Congress will give a boost to some
industries.

So far, the count shows that Democratic challenger Joe Biden narrowly ahead in key states,
but the risk of a prolonged contested election remains.

Back in Europe, it will be a data heavy morning with EZ and UK PMI data due.

The Bank of England's November monetary policy decision is also on schedule. The Telegraph
newspaper reported that the central bank is considering a move into negative interest rates.

(Joice Alves)

*****

More News
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more
26 Oct 2023 07:02

GSK HIV injection regimen gets approval in China

(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.

Read more
25 Oct 2023 16:01

UK earnings, trading statements calendar - next 7 days

Thursday 26 October 
Bank of Ireland Group PLCTrading Statement
Bloomsbury Publishing PLCHalf Year Results
Botswana Diamonds PLCTrading Statement
C&C Group PLCHalf Year Results
e-Therapeutics PLCHalf Year Results
Financials Acquisition CorpTrading Statement
GCP Infrastructure Investments LtdTrading Statement
HarbourVest Global Private Equity LtdHalf Year Results
Hummingbird Resources PLCTrading Statement
Hunting PLCTrading Statement
Inchcape PLCTrading Statement
International Personal Finance PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Renishaw PLCTrading Statement
Standard Chartered PLCQ3 Results
Unilever PLCTrading Statement
WPP PLCTrading Statement
Friday 27 October 
International Consolidated Airlines Group SAQ3 Results
NatWest Group PLCQ3 Results
Monday 30 October 
Airtel Africa PLCHalf Year Results
Computacenter PLCTrading Statement
Glencore PLCTrading Statement
HSBC Holdings PLCQ3 Results
Lok'n Store Group PLCFull Year Results
Pearson PLCTrading Statement
Tuesday 31 October 
BP PLCQ3 Results
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCFull Year Results
Georgia Capital PLCQ3 Results
Grit Real Estate Income Group LtdFull Year Results
RHI Magnesita NVTrading Statement
Spectris PLCQ3 Results
TP ICAP Group PLCTrading Statement
UP Global Sourcing Holdings PLCFull Year Results
Wednesday 1 November 
Asos PLCFull Year Results
Aston Martin Lagonda Global Holdings PLCQ3 Results
Beximco Pharmaceuticals LtdFull Year Results
GSK PLCQ3 Results
Next PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Weir Group PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
25 Oct 2023 09:35

GSK says RSV jab shows promising response in adults aged 50 to 59

(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59.

Read more
25 Oct 2023 07:27

GSK hails success in US RSV vaccine trial

(Sharecast News) - Pharma giant GSK has announced positive preliminary results from a trial of its Arexvy vaccine to treatment respiratory syncytial virus (RSV) disease for a younger patient population in the US.

Read more
16 Oct 2023 08:09

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.

Read more
16 Oct 2023 07:44

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere.

Read more
16 Oct 2023 07:16

GSK nears green light for Jemperli usage in Europe

(Sharecast News) - Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer - paving the way for marketing authorisation by the continent's regulatory body.

Read more
11 Oct 2023 11:51

GSK settles California Zantac lawsuit

(Sharecast News) - GSK has agreed to settle another lawsuit concerning its discontinued heartburn treatment Zantac, the drugs giant confirmed on Wednesday.

Read more
11 Oct 2023 09:17

LONDON BROKER RATINGS: JPMorgan raises Croda; Berenberg cuts Atalaya

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
11 Oct 2023 08:51

LONDON MARKET OPEN: FTSE 100 higher; Travis Perkins warns on profit

(Alliance News) - Stock prices in London opened largely higher on Wednesday as market mood remained resilient, despite the continuing conflict in the Middle East, amid a softening of rhetoric from the US central bank.

Read more
11 Oct 2023 08:36

TOP NEWS: GSK reaches settlement for Zantac litigation in California

(Alliance News) - GSK PLC on Wednesday said that it has reached a confidential settlement in the Cantlay/Harper case, which alleged that the firm's heartburn medication can cause cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.